Sponsor

Vigonvita Life Sciences

Clinical research sponsor

Published trials9

Recruiting shown2

Roles1

SourceClinicalTrials.gov

Clinical trials

9 shown

Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDDNCT06828887 · lead sponsor · 2025-04-03

RECRUITING

Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119NCT06504290 · lead sponsor · 2024-07-16

RECRUITING

Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia AdultsNCT07703956 · lead sponsor · 2026-07-31

NOT_YET_RECRUITING

A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PETNCT06476509 · lead sponsor · 2024-05-30

COMPLETED

Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy VolunteersNCT06105151 · lead sponsor · 2023-10-27

ACTIVE_NOT_RECRUITING

A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy SubjectsNCT05208814 · lead sponsor · 2022-03-31

COMPLETED

Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver FunctionNCT05185011 · lead sponsor · 2021-12-16

COMPLETED

Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial HypertensionNCT04483115 · lead sponsor · 2020-11-16

COMPLETED

The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial HypertensionNCT05948644 · lead sponsor · 2019-04-08

COMPLETED

Sponsor roles

lead sponsor9

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.